跳至主要内容
临床试验/NCT05904951
NCT05904951已完成不适用

Balloon Dilatation Catheter for the Dilation of Stenotic Atherosclerotic Lesions in Coronary Artery or Bypass Grafts: Evaluation of Safety and Performance in Everyday Clinical Practice. The INVADER™ Percutaneous Transluminal Coronary Angioplasty (PTCA) Post Market Clinical Follow-up (PMCF) Study

Alvimedica1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
Device success

研究概览

简要总结

The aim of the present observational study is to collect clinical data on the non-implantable medical device INVADER™ PTCA in the daily use in an unselected population.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • To be a Turkish citizen,
  • To be >18 years of age,
  • Lesion must be successfully crossed with a guidewire without complication,
  • INVADER™ PTCA is used in the primary lesion treated during the procedure,
  • Patient has signed and dated the informed consent.

排除标准

  • Patients who have a known allergic reaction to any of the composition of INVADER™ PTCA Balloon Dilatation Catheter.
  • Device use not consistent with Instructions for Use (IFU).
  • Patients concurrently participating in another medical device or pharmaceutical clinical trial.

结局指标

主要结局

Device success

时间窗: 48 hours after index procedure

Measurement: Percentage of lesions among all attempted lesions with: * Successful device delivery, and * Successful inflation, achievement of appropriate diameter, and deflation of the balloon, and * Decrease in the percent stenosis after balloon procedure, and * No perforation, flow-limiting dissection or reduction in TIMI flow grade, and * No life-threatening arrhythmias (sustained ventricular tachycardia, ventricular fibrillation)

次要结局

  • Procedural success:(48 hours after index procedure)
  • Rate of Target Lesion Failure (TLF)(48 hours after index procedure)
  • Rate of individual components of device success(48 hours after index procedure)

研究者

发起方
Alvimedica
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

The INVADER™ Percutaneous Transluminal Coronary... | 临床试验